Multidrug Resistant Brain Abscess Due to Acinetobacter baumannii Ventriculitis Cleared by Intraventricular and Intravenous Tigecycline Therapy: A Case Report and Review of Literature-Reference-Cited by-同舟云学术

Multidrug Resistant Brain Abscess Due to Acinetobacter baumannii Ventriculitis Cleared by Intraventricular and Intravenous Tigecycline Therapy: A Case Report and Review of Literature

Published:2018-06-29 Issue: Volume:9 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Long Wenyong,Yuan Jian,Liu Jingping,Liu Jinfang,Wu Ming,Chen Xin,Peng Gang,Wu Changwu,Zhang Chi,Wang Xiangyu,Zhao Wei,Liu Qing

Publisher

Frontiers Media SA

Subject

Clinical Neurology,Neurology

Reference14 articles.

1. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections;Karageorgopoulos;Lancet Infect Dis,2008

2. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review;Karaiskos;Int J Antimicrob Agents,2013

3. Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy: a case report;Wu;J Chemother.,2018

4. Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies;Entenza;Int J Antimicrob Agents,2009

5. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas;Paramythiotou;Med Maladies Infect.,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An International, Multicenter Feasibility Study on Active and Continuous Irrigation With Cerebrospinal Fluid Exchange for Improving Outcomes in Cerebral Ventriculitis;Neurosurgery;2024-07-15

2. Intrathecal tigecycline is a safe and effective treatment for central nervous system infections;encephalitis;2023-07-10

3. The Blood–Brain Barrier and Pharmacokinetic/Pharmacodynamic Optimization of Antibiotics for the Treatment of Central Nervous System Infections in Adults;Antibiotics;2022-12-19

4. Intrathecal or Intraventricular Tigecycline Therapy for Central Nervous System Infection Associated with Carbapenem-Resistant Klebsiella pneumoniae;Infection and Drug Resistance;2022-12

5. The Pharmacokinetics/Pharmacodynamics and Neurotoxicity of Tigecycline Intraventricular Injection for the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Intracranial Infection;Infection and Drug Resistance;2022-08